Slides
Page 1
Arteris 2Q 2026 Earnings Presentation Charlie Janac CEO August 6 , 2026 © 2026 Arteris , Inc. Nick Hawkins CFO ARTERIS IP
Page 2
Disclaimer © 2026 Arteris, Inc.2 This presentation and the accompanying oral presentation have been prepared by Arteris, Inc. ("Arteris“ or “the "Company") for informational purposes only and not for any other purpose. Nothing contained in this presentation is, or should be construed as, a recommendation, promise or representation by the presenter or Arteris or any officer, director, employee, agent or advisor of Arteris. This presentation does not purport to be all-inclusive or to contain all of the information you may desire. Information provided in this presentation and the accompanying oral presentation speak only as of the date hereof. This presentation and the accompanying oral presentation include express and implied "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terms such as "anticipate," "believe," "estimate," "expect," "intend," "may," "might," "plan," "project," "will," "would," "should," "could," "can," "predict," "potential," "target," "explore," "continue," or the negative of these terms, and similar expressions intended to identify forward-looking statements. However, not all forward-looking statements contain these identifying words. These statements may relate to our market size and growth strategy, our estimated and projected costs, margins, revenue, expenditures and growth rates (including our 3 rd quarter and 2026 full year guidance), our future results of operations or financial condition, our plans and objectives for future operations, growth, initiatives, or strategies. By their nature, these statements are subject to numerous uncertainties and risks, including factors beyond our control, that could cause actual results, performance or achievement to differ materially and adversely from those anticipated or implied in the statements. These assumptions , uncertainties and risks include, among others, risks related to: market conditions and global economic factors, our ability to access debt and equity financing, our efforts to establish and maintain proper and effective internal controls, and other factors relating to our business, operations and financial performance. It is not possible for us to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results or outcomes to differ materially from those contained in any forward-looking statements we may make. You should not rely upon forward-looking statements as predictions of future events. Although our management believes that the expectations reflected in our statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances described in the forward-looking statements will be achieved or occur. Moreover, neither we, nor any other person, assumes responsibility for the accuracy and completeness of these statements. Recipients are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date such statements are made and should not be construed as statements of fact. Except to the extent required by federal securities laws, we undertake no obligation to update any information or any forward-looking statements as a result of new information, subsequent events, or any other circumstances after the date hereof, or to reflect the occurrence of unanticipated events. This presentation and the accompanying oral presentation also contain estimates and other statistical data made by independent parties and by us relating to market size and growth and other data about our industry. This data involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. In addition, projections, assumptions, and estimates of our future performance and the future performance of the markets in which we compete are necessarily subject to a high degree of uncertainty and risk. In addition to the financials presented in accordance with U.S. generally accepted accounting principles ("GAAP"), this presentation includes the following non-GAAP metrics: non-GAAP operating expenses, non-GAAP operating income (loss) and free cash flow. Non-GAAP metrics have limitations as analytical tools and you should not consider them in isolation or as a substitute for or superior to the most directly comparable financial measures prepared in accordance with U.S. GAAP. There are a number of limitations related to the use of non-GAAP metrics versus their nearest GAAP equivalents. Other companies, including companies in our industry, may calculate non-GAAP metrics differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP metrics as tools for comparison. We urge you to review the reconciliation Arteris' non-GAAP metrics to the most directly comparable GAAP financial measures, and not to rely on any single financial measure to evaluate our business. See the Appendix for reconciliation between each non-GAAP metric and the most comparable GAAP measure. Arteris is unable to provide a reconciliation of certain non-GAAP guidance metrics in this presentation because the corresponding GAAP measures are not accessible on a forward-looking basis. Due to the potential variability and limited visibility of the excluded items, providing such reconciliation would necessitate unreasonable effort. This presentation shall not constitute an offer to sell or the solicitation of an offer to buy securities, nor shall there be any sale of securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Page 3
Achieved record-breaking results on multiple fronts: ACV+Royalties of $99.5 million, a 44% Y/Y increase, as well as record revenue, royalties, and RPO backlog Healthy design activity in the second quarter, with customers reporting 21% Y/Y increase in number of design starts in the trailing twelve months ended June 30 2026 Continued FlexGen success, closing multiple 7-figure deals for FlexGen with major semiconductor customers in 1H26 We completed our ATM fund raising effort, raising $72 million to support development of industry-leading system IP products, global customer support, and future M&A activity Saurabh Sinha will join Arteris as our new CFO, starting September 8th 2026. Saurabh joins Arteris from Aeva Technologies, where he took the company public on NASDAQ, and managed their financial operations, capital allocation, and investor relations © 2026 Arteris, Inc.3 2Q Business Highlights
Page 4
Key Arteris Customer and Ecosystem Highlights from Last Quarter © 2026 Arteris, Inc.4 One of the top US semiconductor design houses building custom ASICs for various hyperscalers using FlexGen smart NoC IP Speedata deployed Arteris in its Callisto processor to run large- volume analytics processing Li Auto has deployed its in-house designed autonomous driving chips in their newest SUV, leveraging Arteris technology SiEngine has selected Arteris for its next-generation SoC platform for intelligent cockpit, ADAS, and AI cockpit-drive fusion solution Arm expanded its partnership with Arteris for Cycuity hardware security assurance technology; already in use on selected Arm CPUs and expanding usage One of the world’s largest hyperscale cloud companies chose to adopt and standardize on Arteris for its infrastructure silicon system IP IC-link by IMEC is collaborating with Arteris as part of their ongoing effort to accelerate and simplify development of next-gen HPC chiplets and ASIC chips
Page 5
Revenue ACV + Royalties RPO Gross Profit* 2Q 2026 Results Revenue, ACV + Royalties, RPO, NG Gross Profit © 2026 Arteris, Inc.5 2Q 2025 1Q 2026 2Q 20262Q 2026 Guidance $16.5M $69.1M $99.3M Non-GAAP: $15.0M (91%) $24.1M (+46% Y/Y) $99.5M (+44% Y/Y) $135M (+36% Y/Y) Non-GAAP: $21.0M (87%) $22.9M $92.8M $118M Non-GAAP: $20.1M (87%) $23M - $24M $95M - $99M N/A N/A *Non-GAAP measure: See appendix for reconciliation to closest GAAP measure
Page 6
Operating Expenses Operating Income (Loss) 2Q 2026 Results Operating Expenses, Operating Income (Loss) © 2026 Arteris, Inc.6 2Q 2025 1Q 2026 2Q 20262Q 2026 Guidance Non-GAAP*: $18.6M GAAP: $23.0M Non-GAAP*: ($3.5M) GAAP: ($8.2M) Non-GAAP*: $25.5M (+37% Y/Y) GAAP: $34.4M Non-GAAP*: ($4.6M) (-29% Y/Y) GAAP: ($13.9M) Non-GAAP*: $22.6M GAAP: $29.0M Non-GAAP*: ($2.5M) GAAP: ($9.3M) Non-GAAP*: ($3M) – ($2M) N/A *Non-GAAP measure: See appendix for reconciliation to closest GAAP measure.
Page 7
2Q 2025 1Q 2026 2Q 20262Q 2026 Guidance 2Q 2026 Results Free Cash Flow, Cash © 2026 Arteris, Inc.7 Free Cash Flow* ($2.8M) $8.6M($7.4M) $2M – $8M Cash, Cash Equivalents & Investments $53.9M $123M$41.9M N/A *Non-GAAP measure: See appendix for reconciliation to closest GAAP measure
Page 8
FY 2026 Guidance Guidance © 2026 Arteris, Inc.8 3Q 2026 Guidance ACV + Royalties1 $99M - $103M Revenue2 $24M - $25M Non-GAAP Op. Income ($3M) – ($1M) ACV + Royalties3 $102M - $106M (maintained) Revenue4 $95M - $98M (+$3.5M from previous guide) Non-GAAP Op. Income ($10M) – ($7M) (-$2M from previous guide) Free Cash Flow $5M – $9M (maintained) 1. 101M at the midpoint, +$26.1M Y/Y (+35%) 2.24.5M at the midpoint, +$7.1M Y/Y (+41%) 3. 104M at the midpoint, +$20.4M Y/Y (+24%) 4. 96.5M at the midpoint, +$25.9M Y/Y (+37%) Arteris has not provided a quantitative reconciliation of its 3Q 2026 or FY 2026 guidance for non- GAAP operating income or free cash flow, in either case, to the closest GAAP measure, within this press release because the Company is unable, without making unreasonable efforts, to calculate certain reconciling items with confidence. These items include, but are not limited to, inventory valuation adjustment and equity securities fair value adjustment. These items, which could materially affect the computation of forward-looking GAAP measures, are inherently uncertain and depend on various factors, some of which are outside of the Company’s control.
Page 9
Appendix - Non-GAAP Financial Measures © 2026 Arteris, Inc.9 To supplement our financial results, which are prepared and presented in accordance with GAAP, we use certain non-GAAP financial measures, as described below, to understand and evaluate our core performance. These non-GAAP measures, which may be different than similarly-titled measures used by other companies, are presented to enhance investors’ overall understanding of our financial performance and should not be considered in isolation, as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. We define "Non-GAAP gross profit" and "Non-GAAP gross margin" as GAAP gross profit and GAAP gross margin, respectively, adjusted for stock-based compensation expense included in cost of revenue and amortization of acquired intangible assets included in cost of revenue. We define “Non-GAAP loss from operations” as our GAAP loss from operations adjusted to exclude stock-based compensation expense, amortization of acquired intangible assets and acquisition-related costs, which include advisory, legal, accounting, valuation, other professional or consulting fees, integration costs and changes in the fair value of the contingent consideration related to our acquisition of Cycuity. We define “Non-GAAP net loss” as our net loss adjusted to exclude stock-based compensation, amortization of acquired intangible assets and acquisition-related costs. The above items are excluded from our Non-GAAP gross profit, Non-GAAP operating expenses and Non-GAAP operating income (loss) because these items are non-cash in nature, or are not indicative of our core operating performance, and render comparisons with prior periods and competitors less meaningful. We believe Non-GAAP gross profit, Non-GAAP operating expenses and Non-GAAP operating income (loss) provide useful supplemental information to investors and others in understanding and evaluating our results of operations, as well as provide a useful measure for period-to-period comparisons of our business performance. We define free cash flow as net cash provided by (used in) operating activities less cash used for purchases of property and equipment. We believe that free cash flow is a useful indicator of liquidity that provides information to management and investors, even if negative, about the amount of cash used in our operations other than that used for investments in property and equipment.
Page 10
Appendix - GAAP To Non-GAAP Reconciliation Gross profit © 2026 Arteris, Inc.10 Three Months Ending: In $ thousands Jun 30, Mar 31, Jun 30, 2025 2026 2026 Revenue 16,502 22,936 24,134 Gross profit 14,760 19,686 20,527 Add: Stock-based compensation expense included in cost of revenue 232 321 384 Amortization of acquired intangible assets 50 50 50 Non-GAAP gross profit 15,042 20,057 20,961 Non-GAAP gross margin 91% 87% 87%
Page 11
Appendix - GAAP To Non-GAAP Reconciliation Operating expenses © 2026 Arteris, Inc.11 Three Months Ending: In $ thousands Jun 30, Mar 31, Jun 30, 2025 2026 2026 Operating expenses 23,008 28,986 34,435 Less: Stock-based compensation expense 4,265 5,190 5,963 Amortization of acquired intangible assets 167 636 727 Acquisition-related costs - 584 2,215 Non-GAAP operating expenses 18,576 22,576 25,530
Page 12
Appendix - GAAP To Non-GAAP Reconciliation Operating income (loss) © 2026 Arteris, Inc.12 Three Months Ending: In $ thousands Jun 30, Mar 31, Jun 30, 2025 2026 2026 Operating Income (Loss) (8,248) (9,300) (13,908) Add: Stock-based compensation expense 4,497 5,511 6,347 Amortization of acquired intangible assets 217 686 777 Acquisition-related costs - 584 2,215 Non-GAAP Operating Income (Loss) (3,534) (2,519) (4,569)
Page 13
Appendix –Free Cash Flow © 2026 Arteris, Inc.13 Three Months Ending: In $ thousands Jun 30, Mar 31, Jun 30, 2025 2026 2026 Net cash provided by (used in) operating activities (2,485) (7,062) 9,210 Less: Purchase of property and equipment 355 295 595 Free cash flow (2,840) (7,357) 8,615